FDA accepts NuPathe's NDA for migraine patch

> FDA accepts NuPathe's NDA for Zelrix migraine patch. Story | Backgrounder

> Nanoparticles used as carriers in vaccine against stomach flu. Report

> Drug delivery job of the week: Principal Industrial Designer, Merck, Summit, NJ., Position will be responsible for managing programs and leading industrial design and human factors engineering of injection and inhalation drug delivery devices from conceptualization through commercialization. Job listing

> Drug delivery patent application of the week: Drug Delivery Nanodevice, its Preparation Method and Uses Thereof Patent Application

> Drug delivery tech transfer opportunity of the week: Novel Peptide Composition to Facilitate Drug Delivery, University of California, Santa Barbara Details

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.